Thrombolysis in myocardial infarction (TIMI) risk score

The thrombolysis in myocardial infarction (TIMI) risk score is a prognostic risk stratification system that categorises the risk of death and ischemic events in patients with unstable angina / NSTEMI and provides a basis for therapeutic decision making. It is thought to have potential to improve the management of patients presenting to hospital with undifferentiated chest pain where ischaemic heart disease is a potential diagnosis 3.

Score calculation

One point is given for each:

  • age ≥65 years
  • aspirin use within the last 7 days (patient has chest pain despite as required use in past 7 days)
  • at least 2 angina episodes in the last 24 hours
  • ST changes of at least 0.5 mm in contiguous leads
  • elevated serum cardiac biomarkers
  • known coronary artery disease (CAD) (coronary stenosis ≥50%)
  • at least 3 risk factors for coronary artery disease, which include
    • hypertension >140/90 or on anti-hypertensives
    • current cigarette smoking 
    • low HDL cholesterol (<40 mg/dL)
    • diabetes mellitus
    • family history of premature coronary artery disease
      • male first-degree relative or father younger than 55 years
      • female first-degree relative or mother younger than 65 years
Score interpretation

A percentage risk at 14 days of all-cause mortality, new or recurrent MI, or severe recurrent ischemia requiring urgent revascularisation.

The predicted risk is as follows 4:

  • score of 0-1 = 4.7% risk
  • score of 2 = 8.3% risk
  • score of 3 = 13.2% risk
  • score of 4 = 19.9% risk
  • score of 5 = 26.2% risk
  • score of 6-7 = at least 40.9% risk

See also

Share article

Article Information

rID: 41677
System: Cardiac
Synonyms or Alternate Spellings:
  • Thrombolysis in myocardial infarction risk score
  • TIMI risk score

Support Radiopaedia and see fewer ads

Updating… Please wait.
Loadinganimation

Alert accept

Error Unable to process the form. Check for errors and try again.

Alert accept Thank you for updating your details.